120 related articles for article (PubMed ID: 19298548)
1. Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment.
Kowalzick L; Eickenscheidt L
J Dtsch Dermatol Ges; 2009 Jun; 7(6):538-40. PubMed ID: 19298548
[TBL] [Abstract][Full Text] [Related]
2. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
3. Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.
Heber G; Helbig D; Pönitzsch I; Wetzig T; Harth W; Simon JC
J Dtsch Dermatol Ges; 2009 Jun; 7(6):534-6. PubMed ID: 19250248
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
Ray CM; Kluk M; Grin CM; Grant-Kels JM
Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
[TBL] [Abstract][Full Text] [Related]
5. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
[TBL] [Abstract][Full Text] [Related]
6. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
Rapprich H; Hagedorn M
J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod in the treatment of extensive recurrent lentigo maligna.
Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod clears invasive melanoma.
Grady BE; Spencer JM
Cutis; 2016 Nov; 98(5):E28-E30. PubMed ID: 28040822
[TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod in the treatment of metastatic melanoma to skin.
Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
[No Abstract] [Full Text] [Related]
10. Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.
Turza K; Dengel LT; Harris RC; Patterson JW; White K; Grosh WW; Slingluff CL
J Cutan Pathol; 2010 Jan; 37(1):94-8. PubMed ID: 19602071
[TBL] [Abstract][Full Text] [Related]
11. Clearance of invasive melanoma with topical imiquimod.
Moon SD; Spencer JM
J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
Green DS; Bodman-Smith MD; Dalgleish AG; Fischer MD
Br J Dermatol; 2007 Feb; 156(2):337-45. PubMed ID: 17223875
[TBL] [Abstract][Full Text] [Related]
13. [Imiquimod for the treatment of skin metastases of melanoma].
Nagore E; Botella-Estrada R; Sanmartín O; Guillén C
Actas Dermosifiliogr; 2005 Oct; 96(8):549-50. PubMed ID: 16476296
[No Abstract] [Full Text] [Related]
14. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Miller AK; Dusing R; Meggison A; Aires D
J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Florin V; Desmedt E; Vercambre-Darras S; Mortier L
Invest New Drugs; 2012 Aug; 30(4):1641-5. PubMed ID: 21748297
[TBL] [Abstract][Full Text] [Related]
16. Locoregional cutaneous metastases of malignant melanoma and their management.
Wolf IH; Richtig E; Kopera D; Kerl H
Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216
[TBL] [Abstract][Full Text] [Related]
17. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
Florin V; Vercambre-Darras S; Piette F; Mortier L
Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
[No Abstract] [Full Text] [Related]
18. Topical treatment of melanoma skin metastases with imiquimod: a review.
Sisti A; Sisti G; Oranges CM
Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
Powell AM; Robson AM; Russell-Jones R; Barlow RJ
Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
[TBL] [Abstract][Full Text] [Related]
20. Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
Vereecken P; Mathieu A; Laporte M; Petein M; Velu T; Awada A; Heenen M
Dermatology; 2003; 206(3):279-80. PubMed ID: 12673091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
